Nanotechnologies et veille santaire finale

NANOTECHNOLOGIES OPPORTUNITIES AND RISKS Présenté par KHAN Imran Entretien à l’institut romand de santé au travail Le 8 Juillet 2011

INTRODUCTION ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Vegetal oil Biodegradables fuels or dissolvants Biopolymers

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object]

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Treatment more efficient and speed

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Cytotoxic action

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Miniaturization project

INTRODUCTION Domains and applications ,[object Object],[object Object]

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],D ivision into more little droplets Progressing in canals Specific reaction chambers

INTRODUCTION Domains and applications ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object]

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],Tiny and highly mobile Lungs Skin Blood stream Organs Cells Intestinal tracts

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Intrinsic chemistry Extrinsic chemistry Pathogenic agents

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Activation fibrosis Aortic endothelial cell apoptosis Vascular and cardiac toxicity Brain damage

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],Inflammatory reaction Fibrosis Cancers

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Bioaccumulation et biopersistancy

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Pollution risks ? OR Case by case studies Different properties

NANOTECHNOLOGY RISKS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

RISK MANAGEMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

RISK MANAGEMENT ,[object Object]

RISK MANAGEMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

RISK MANAGEMENT ,[object Object],SP1 : Detection and characterization techniques

RISK MANAGEMENT ,[object Object],SP2 : Health hazard assessment

RISK MANAGEMENT ,[object Object],SP3 : Development of secure industrial production systems and safe applications

RISK MANAGEMENT ,[object Object],SP4 : Societal and Environmental aspects

RISK MANAGEMENT ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],REACH

CONCLUSIONS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

CONCLUSIONS ,[object Object],Thanks for your attention !!!

Nanotechnologies et veille santaire finale

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (20)

Similar a Nanotechnologies et veille santaire finale

Similar a Nanotechnologies et veille santaire finale (20)

Último

Último (20)

Nanotechnologies et veille santaire finale